Health Dictionary Find a Doctor

Goiter natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

Overview

If left untreated, goiter will continue to grow in size. Slow growth of the nodules is observed in benign goiter. Rapid growth and large size of goiter causing compressive symptoms may be suggestive of thyroid cancer. Common complications of goiter include those related to the enlarged thyroid gland and those related to thyroidectomy. Prognosis is generally good for benign goiter. Although the prognosis is good and the risk is low, caution is advised to prevent the possible development of malignancy. Careful monitoring of size, shape and consistency associated with pain is recommended. Radiation exposure has been attributed to the possible development of malignancy.

Natural History, Complications, and Prognosis

Natural History

Complications

Complications related to the enlarged gland:

Complications related to thyroidectomy:

Prognosis

  • Prognosis is generally good for benign goiters. [5]
  • Although the prognosis is good and the risk is low, caution is advised for the possible development of malignancy.
  • Careful monitoring of size, shape and consistency associated with pain is advised.
  • Radiation exposure has been attributed to the possible development of malignancy.

References

  1. 1.0 1.1 “Reorganized text”. JAMA Otolaryngol Head Neck Surg. 141 (5): 428. 2015. doi:10.1001/jamaoto.2015.0540. PMID 25996397.
  2. 2.0 2.1 Shen WT, Kebebew E, Duh QY, Clark OH (2004). “Predictors of airway complications after thyroidectomy for substernal goiter”. Arch Surg. 139 (6): 656–9, discussion 659-60. doi:10.1001/archsurg.139.6.656. PMID 15197094.
  3. Bonnema SJ, Bennedbaek FN, Ladenson PW, Hegedüs L (2002). “Management of the nontoxic multinodular goiter: a North American survey”. J Clin Endocrinol Metab. 87 (1): 112–7. doi:10.1210/jcem.87.1.8169. PMID 11788632.
  4. Nielsen VE, Bonnema SJ, Hegedüs L (2006). “Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial”. J Clin Endocrinol Metab. 91 (4): 1317–22. doi:10.1210/jc.2005-2137. PMID 16434453.
  5. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F; et al. (1977). “The spectrum of thyroid disease in a community: the Whickham survey”. Clin Endocrinol (Oxf). 7 (6): 481–93. PMID 598014.

Template:WH Template:WS

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH